null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

Anti-CavBeta2 Antibody [N8b/1 (Formerly sold as S8B-1)]

SKU STMA00095
Antibody Type Monoclonal
Applications WB
Applications IHC
Applications ICC/IF
Applications IP
Applications AM
Reactivity Human
Reactivity Mouse
Reactivity Rat
Host Species Mouse
Isotype IgG1
$854
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

CavBeta2 Antibody [N8b/1 (Formerly sold as S8B-1)]

CavBeta2 Antibody [N8b/1 (Formerly sold as S8B-1)] is a mouse monoclonal antibody directed against CavBeta2, offered by Assay Genie for research applications. Reported applications include WB, IHC, ICC/IF, IP and AM. Reported reactivity: Human, Mouse and Rat. Supplied as IgG1, purified by Protein G.

The Cav Beta 2 subunit is a critical auxiliary component of voltage-gated calcium channels (VGCCs), playing a central role in neuronal excitability and synaptic signaling. It facilitates the trafficking of the pore-forming alpha1 subunit to the plasma membrane by masking an endoplasmic reticulum (ER) retention signal, ensuring proper channel localization and surface expression. This process is essential for the functional assembly of VGCCs at the neuronal membrane. Beyond trafficking, Cav Beta 2 directly influences the biophysical properties of calcium channels, including voltage sensitivity, activation kinetics, and inactivation dynamics. These properties are crucial for regulating calcium influx, which in turn governs neurotransmitter release, gene expression, and neuronal survival. Dysregulation of Cav Beta 2 function has been implicated in several neurodegenerative diseases, where altered calcium homeostasis contributes to synaptic dysfunction, excitotoxicity, and progressive neuronal loss. Understanding the molecular mechanisms by which Cav Beta 2 modulates VGCCs offers valuable insights into the pathophysiology of disorders such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis (ALS). As a modulator of both channel trafficking and function, Cav Beta 2 represents a promising target for therapeutic intervention aimed at restoring calcium signaling balance in neurodegenerative conditions. This antibody is also available conjugated to ATTO 390, ATTO 488, ATTO 594, APC, Biotin, FITC, HRP, PerCP and RPE. Supplied in 100 µg. For research use only; not for diagnostic or therapeutic procedures.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose